Angiodroid SpA is an Italian innovative Company that projects and trades solutions for the medical market. Angiodroid® The CO2 Injector is our main product. It is a Carbon Dioxide (CO2) Injector for Interventional Radiology procedures and represents the perfect solution for the treatment of patients with: • Contrast Induced Nephropathy (CIN) risk • Diabetic Disease • Renal Failure • Intolerance to Iodinated contrast media The use of CO2 in Peripheral Angiography has been common practice for many decades. To date, however, it has not the proper success due to the lack of advanced technology which could support operators during the procedures. Until now, the market solution was the use of manual injection kits (that means no procedural repeatability, no control of injection pressure and air contamination risk). Angiodroid® The CO2 Injector, whose main fields of application are Interventional Radiology & Vascular Surgery, is the perfect solution to all these problems and is the only injector: • 100 % automatic • 100 % safe • 100 % digital • 100 % user friendly More info at www.angiodroid.com
Looking for a particular Angiodroid employee's phone or email?
The Angiodroid annual revenue was $2 million in 2026.
Davide Arcidiacono is the CEO of Angiodroid.
31 people are employed at Angiodroid.
Angiodroid is based in San Lazzaro di Savena, Emilia-Romagna.
The NAICS codes for Angiodroid are [33, 339].
The SIC codes for Angiodroid are [384, 38].